Investment Trusts

Target Healthcare REIT plc

THRL:LSE

Target Healthcare REIT plc

Actions
  • Price (GBX)84.30
  • Today's Change0.40 / 0.48%
  • Shares traded1.02m
  • 1 Year change0.00%
  • Beta0.5585
Data delayed at least 15 minutes, as of Nov 22 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Target Healthcare REIT plc is a United Kingdom-based real estate investment trust. The Company’s investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth from investing in a diversified portfolio of freehold and long leasehold care homes that are let to care home operators, and other healthcare assets in the United Kingdom. Its portfolio includes Chawley Grove, Roden Hall, The Oaks, Goldwell Manor, Woodland View, and The Manor. The Company’s portfolio comprised 94 properties let to 33 tenants. The Company invests in a portfolio of care homes, predominantly in the United Kingdom, which are let to care home operators on full repairing and insuring leases. It provides fit-for-purpose real estate for the long term to care providers who demonstrate operational capabilities. The Company’s investment manager and alternative investment fund manager is Target Fund Managers Limited.

  • Revenue in GBP (TTM)69.55m
  • Net income in GBP73.02m
  • Incorporated2019
  • Employees0.00
More ▼

Profile

Management group(s)Target Fund Managers Limited
AIC sectorProperty - UK Healthcare
ISINGB00BJGTLF51
Launch date07 Mar 2013
Share typeOrdinary Share
StructureInvestment Trust
Base currencyGBP

Objective

The Group pursues its objective by investing in a portfolio of care homes, predominantly in the UK, that are let to care home operators on full repairing and insuring leases that are subject to annual uplifts based on increases in the UK retail prices index (subject to caps and collars) or fixed uplifts. The Group is also able to generate up to 15% of its gross income, in any financial year, from non-rental revenue or profit related payments from care home operators under management contracts in addition to the rental income due under fully repairing and insuring leases.

Managed by

Kenneth MacKenzie, John Flannelly, Andrew Brown, Gordon Bland, Scott Steven, Donald Cameron

Management & contract fees

NAV up to and including GBP 500m, annual fee is 1.05%; Above GBP 500m and up to and including GBP 750m, fee is 0.95%; Above GBP 750m and up to and including GBP 1bn, fee is 0.85%; Above GBP 1bn and up to and including GBP 1.5bn, fee is 0.75%; Above GBP 1.5bn, fee is 0.65%. No performance fee. Contract is terminable on 24 months notice.

Institutional shareholders

32.99%Per cent of shares held by top holders
HolderShares% Held
Baillie Gifford & Co.as of 30 Jun 202325.36m4.09%
Premier Fund Managers Ltd.as of 30 Jun 202324.35m3.93%
Alder Investment Management Ltd.as of 30 Jun 202323.68m3.82%
Investec Wealth & Investment Ltd.as of 30 Jun 202323.39m3.77%
Valu-Trac Investment Management Ltd.as of 31 Oct 202421.00m3.39%
Schroder & Co. Ltd.as of 31 Dec 202319.75m3.19%
CCLA Investment Management Ltd.as of 30 Jun 202317.92m2.89%
Rathbones Investment Management Ltd.as of 30 Jun 202317.46m2.82%
West Yorkshire Pension Fundas of 31 Mar 202416.49m2.66%
CG Asset Management Ltd.as of 31 Oct 202415.23m2.46%
More ▼
Data from 31 Mar 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.